Drug efficacy reprogramming against aggressive human prostate cancer
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36165
下载链接
链接失效反馈官方服务：
资源简介：
We enriched for prostate cancer cells by the selection system used in human iPS purification. Gene expression signature-based chemical prediction enabled us to identify candidate drugs for reverting the EOS (early transposon promoter, OCT4 and SOX2 enhancer) signature with chemoresistance into a chemosensitive phenotype. We compared the gene expression between control and EOS-selected cancer cells.
创建时间：
2019-03-25
